BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kaposi Sarcoma AND MYC, c-Myc, 4609, ENSG00000136997 AND Treatment
15 results:

  • 1. Network Pharmacology-Based Identification of Key Pharmacological Mechanism of Shen-qi-di-huang Decoction Acting on Uremia.
    Zhang X; Chen XF; Chen WJ; Ding H; Zhang BX
    Altern Ther Health Med; 2024 Jan; 30(1):44-50. PubMed ID: 37773677
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Echinomycin as a promising therapeutic agent against KSHV-related malignancies.
    Chen J; Lin Z; Song J; Plaisance-Bonstaff K; James J; Mu S; Post SR; Dai L; Qin Z
    J Hematol Oncol; 2023 May; 16(1):48. PubMed ID: 37143124
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. DNA damage triggers an interplay between wtp53 and c-myc affecting lymphoma cell proliferation and kaposi sarcoma herpesvirus replication.
    Arena A; Gilardini Montani MS; Romeo MA; Benedetti R; Gaeta A; Cirone M
    Biochim Biophys Acta Mol Cell Res; 2022 Jan; 1869(1):119168. PubMed ID: 34728235
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The anti-malaria agent artesunate exhibits cytotoxic effects in primary effusion lymphoma.
    Ishikawa C; Mori N
    Invest New Drugs; 2021 Feb; 39(1):111-121. PubMed ID: 32885355
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Global epigenomic analysis of KSHV-infected primary effusion lymphoma identifies functional
    Park A; Oh S; Jung KL; Choi UY; Lee HR; Rosenfeld MG; Jung JU
    Proc Natl Acad Sci U S A; 2020 Sep; 117(35):21618-21627. PubMed ID: 32817485
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Narciclasine, an isocarbostyril alkaloid, has preferential activity against primary effusion lymphoma.
    Gopalakrishnan R; Matta H; Choi S; Chaudhary PM
    Sci Rep; 2020 Mar; 10(1):5712. PubMed ID: 32235878
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Immunomodulatory drugs target IKZF1-IRF4-myc axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors.
    Gopalakrishnan R; Matta H; Tolani B; Triche T; Chaudhary PM
    Oncogene; 2016 Apr; 35(14):1797-810. PubMed ID: 26119939
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Targeting myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors.
    Tolani B; Gopalakrishnan R; Punj V; Matta H; Chaudhary PM
    Oncogene; 2014 May; 33(22):2928-37. PubMed ID: 23792448
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A role for virally induced reactive oxygen species in kaposi's sarcoma herpesvirus tumorigenesis.
    Ma Q; Cavallin LE; Leung HJ; Chiozzini C; Goldschmidt-Clermont PJ; Mesri EA
    Antioxid Redox Signal; 2013 Jan; 18(1):80-90. PubMed ID: 22746102
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Mechanism of glycyrrhizic acid inhibition of kaposi's sarcoma-associated herpesvirus: disruption of CTCF-cohesin-mediated RNA polymerase II pausing and sister chromatid cohesion.
    Kang H; Lieberman PM
    J Virol; 2011 Nov; 85(21):11159-69. PubMed ID: 21880767
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma.
    Sarosiek KA; Cavallin LE; Bhatt S; Toomey NL; Natkunam Y; Blasini W; Gentles AJ; Ramos JC; Mesri EA; Lossos IS
    Proc Natl Acad Sci U S A; 2010 Jul; 107(29):13069-74. PubMed ID: 20615981
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Induction of programmed cell death in kaposi's sarcoma cells by preparations of human chorionic gonadotropin.
    Samaniego F; Bryant JL; Liu N; Karp JE; Sabichi AL; Thierry A; Lunardi-Iskandar Y; Gallo RC
    J Natl Cancer Inst; 1999 Jan; 91(2):135-43. PubMed ID: 9923854
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Human herpesvirus-8-associated body cavity-based lymphoma in human immunodeficiency virus-infected patients: a unique B-cell neoplasm.
    Karcher DS; Alkan S
    Hum Pathol; 1997 Jul; 28(7):801-8. PubMed ID: 9224748
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Consensus-interferon and platelet-derived growth factor adversely regulate proliferation and migration of kaposi's sarcoma cells by control of c-myc expression.
    Köster R; Blatt LM; Streubert M; Zietz C; Hermeking H; Brysch W; Stürzl M
    Am J Pathol; 1996 Dec; 149(6):1871-85. PubMed ID: 8952524
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Immunodeficiency and its relation to lymphoid and other malignancies.
    Tossing G
    Ann Hematol; 1996 Oct; 73(4):163-7. PubMed ID: 8890703
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.